Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 76Leukemia 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Myelomonocytic, Acute 16Leukemia, Monocytic, Acute 16Congenital Abnormalities 16Leukemia, Megakaryoblastic, Acute 14Leukemia, Erythroblastic, Acute 14Myelodysplastic Syndromes 11Leukemia, Promyelocytic, Acute 8Leukemia, Myelomonocytic, Chronic 8Anemia, Refractory, with Excess of Blasts 8Recurrence 6Myeloproliferative Disorders 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 4Lymphoma 3Leukemia, Myeloid, Chronic-Phase 3Blast Crisis 3Neutropenia 2Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Carcinoma, Hepatocellular 2Thrombocythemia, Essential 1Sarcoma, Synovial 1

Interventions

Sorafenib 42Bevacizumab 16Oxaliplatin 13Radiosurgery 10Gemcitabine 10Doxorubicin 10Capecitabine 10Leucovorin 9Hepatectomy 9Fluorouracil 9Cisplatin 9Radiofrequency Ablation 8Nivolumab 8pembrolizumab 7Drug Therapy 7Carboplatin 7Irinotecan 6Cryosurgery 6Talaporfin 5Mitomycin 5Everolimus 5Erlotinib Hydrochloride 5Electroporation 5spartalizumab 4Sunitinib 4Melphalan 4Ipilimumab 4Epirubicin 4Embolization, Therapeutic 4regorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Liver Neoplasms × Idarubicin × Clear all
NCT02185768 2025-07-04

IDASPHERE II

Federation Francophone de Cancerologie Digestive

Phase 2 Completed
46 enrolled 11 charts
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡